Have you herd? Indirect flu vaccine effects are critically important

The Lancet Public Health

Volumn 2, Issue 2, 2017, Pages e57-e58

  Fisman, David N ^a,b   Bogoch, Isaac I ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HERD IMMUNITY; HUMAN; INFLUENZA VACCINATION; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; NOTE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL INFLUENZA; VIRUS MUTATION;

EID: 85019851021     PISSN: None     EISSN: 24682667     Source Type: Journal    
DOI: 10.1016/S2468-2667(17)30004-X     Document Type: Note

References (9)

1. Simonsen, L, Fukuda, K, Schonberger, LB, Cox, NJ, The impact of influenza epidemics on hospitalizations. J Infect Dis 181 (2000), 831–837.
2. Molinari, NA, Ortega-Sanchez, IR, Messonnier, ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25 (2007), 5086–5096.
3. Galvani, AP, Reluga, TC, Chapman, GB, Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci USA 104 (2007), 5692–5697.
4. Reichert, TA, Sugaya, N, Fedson, DS, Glezen, WP, Simonsen, L, Tashiro, M, The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001), 889–896.
5. Loeb, M, Russell, ML, Moss, L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 303 (2010), 943–950.
6. Loeb, M, Russell, ML, Manning, V, et al. Live attenuated versus inactivated influenza vaccine in Hutterite children: a cluster randomized blinded trial. Ann Intern Med 165 (2016), 617–624.
7. Hodgson, D, Baguelin, M, van Leeuwen, E, et al. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. Lancet Public Health, 2017 published online Jan 10. http://dx.doi.org/10.1016/S2468-2667(16)30044-5.
8. Pitman, R, Fisman, D, Zaric, GS, et al., ISPOR-SMDM Modeling Good Research Practices Task Force. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–5. Value Health 15 (2012), 828–834.
9. Lexau, CA, Lynfield, R, Danila, R, et al., Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005), 2043–2051.